Latest News in the pharma Industry
Biopharma News
Alvotech and DKSH extend biosimilar partnership in Asia
22 Sep 2020
The companies will commercialize six new biosimilar candidates addressing multiple therapeutic areas.
Read more
Micreos initiates trial to evaluate world's first endolysin-drug as a therapy for atopic dermatitis
22 Sep 2020
The targeted removal of one particular bacterial species from the skin microbiome, while preserving the beneficial ones, represents a new way to treat atopic dermatitis.
Read more
T-knife and Catalent sign tech transfer and manufacturing agreement
21 Sep 2020
Catalent to manufacture clinical batches of T-knife's platform process for TCR-based cell therapy at its site in Gosselies, Belgium, for European trials in 2021.
Read more
TESSA technology for robust and reproducible AAV manufacture at scale
21 Sep 2020
Novel, plasmid-free manufacturing system reduces the cost of goods and improves AAV quality to enable development of safer gene therapies.
Read more
Humanigen and Lonza collaborate to expand manufacturing of COVID-19 therapeutic candidate
15 Sep 2020
Humanigen's proprietary monoclonal antibody may prevent and treat cytokine storm, which is believed to trigger the acute respiratory distress syndrome in severe cases of COVID-19.
Read more
Univercells Technologies introduces new upstream platform for virus manufacturing
15 Sep 2020
The NevoLine Upstream platform has been designed to address the needs of gene therapy and vaccine innovators and CDMOs for robust and cost-effective upstream viral vectors manufacturing.
Read more
INOVIO signs up Thermo Fisher to support COVID-19 vaccine production
8 Sep 2020
The CDMO will support INOVIO's plans to have 100 million doses of COVID-19 vaccine candidate INO-4800 manufactured in 2021.
Read more
Mylan to acquire Aspen's thrombosis business in Europe
8 Sep 2020
The transaction will further complement and expand Mylan's complex injectables offering and presence in hospitals.
Read more
Exelixis and Catalent collaborate to develop antibody-drug conjugates
8 Sep 2020
The partnership will focus on developing multiple ADCs using Catalent’s proprietary SMARTag site-specific bioconjugation technology.
Read more
Mylan and Biocon Biologics launch Lantus biosimilar in the US
1 Sep 2020
Semglee available in vial and pen presentations at a 65% discounted list price, the lowest available for a long-acting insulin glargine on the market.
Read more
Pfizer sells biologics manufacturing facility in Adelaide
1 Sep 2020
Bridgewest to develop the site into a full-service contract development and manufacturing organization.
Read more
Oral Solid Dose Regulatory Hurdles and How to Approach Them
28 Aug 2020
In your quest to meet the regulatory requirements for your oral solids project, you may encounter significant hurdles. Anticipating these early on and thoroughly planning your approach can help. Experts in the Pfizer CentreOne global network, Gillian M...
Read more